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Background: The purpose of this research is to compare the histological and immunohistochemical changes
induced by fixed combinations of timolol maleate and prostaglandin analogues in the rabbit conjunctiva. Thirty left
eyes of rabbits, divided into three groups, were treated for 30 days with the following combinations of drugs:
bimatoprost 0.03% + timolol 0.5%, travoprost 0.004% + timolol 0.5% and latanoprost 0.005 + timolol 0.5%. The right
eyes served as controls and received no medication. At the end of the experiment, after enucleation, the
conjunctivas were assessed through histomorphometry (number of inflammatory and goblet cells, epithelial
thickness) and immunohistochemistry (anti-actin antibody to assess the degree of fibrosis).
Results: Histomorphometrically, there was infiltration of inflammatory cells in all the treated eyes. An increased
number of goblet cells was observed with the use of all fixed combinations of prostaglandin analogues associated
with timolol maleate in comparison with the control group. The combination travoprost + timolol resulted in more
intense fibrosis. The effect of bimatoprost + timolol caused an intermediate reaction pattern among the other
drugs, fostering higher numbers of goblet cells in the conjunctival epithelium, more than the other fixed
combinations in this study. There was a difference in the comparison of goblet cells of eyes treated with
bimatoprost + timolol (16.11 ± 2.42) and of those treated with latanoprost + timolol (13.18 ± 1.60) (P = 0.016).
Conclusion: It was found that all fixed combinations of prostaglandins analogues + timolol induce a reaction in
the conjunctiva, increasing the inflammatory infiltrate.
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Glaucoma is an optic neuropathy, which is progressive,
chronic, multifactorial and often associated with increased
intraocular pressure, and requires long-term treatment
with topical hypotensive medication [1]. Several classes of
drugs are currently available for treating glaucoma, includ-
ing cholinergic agents, beta blockers, alpha adrenergic
agonists, carbonic anhydrase inhibitors, and more recently
prostaglandins analogues (PG) and the fixed combinations* Correspondence: nubiavanessa@gmail.com
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in any medium, provided the original work is p(FC) of alpha adrenergic agonists, carbonic anhydrase
inhibitors or prostaglandin analogues associated with
timolol 0.5% [2]. PG analogues increase the uveoscleral
outflow and can reduce intraocular pressure up to 40% of
its initial value [3-5]. Systemic secondary side effects
induced by topical PG analogues are rare. Local secondary
side effects caused by these drugs are thus reported: con-
junctival hyperemia that can be seen in 40% of patients
[6], double the amount of what is found in patients using
timolol [7], and in addition to iris hyperpigmentation
and periorbicular hyperpigmentation, excessive growth
of eyelashes [8-10]. In patients treated with topical
medications, the conjunctiva acts as a semipermeablean Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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sorption of ocular hypotensors [11]. Moreover, the con-
junctiva responds to the chronic antiglaucoma treatment
drug with inflammation, scarring, keratinization and
neovascularization, which may directly affect its architec-
ture and function [12]. Some studies have shown that the
main topical medications used to treat glaucoma increase
the number of fibroblasts and inflammatory cells in
the conjunctival substantia propria and induce epithelial
metaplasia, causing changes in its structure. High
concentrations of macrophages, lymphocytes, mast cells
and fibroblasts, in addition to the reduction of goblet cell
density, were reported in the conjunctiva in patients hav-
ing chronic treatment with beta blockers [13]. These cellu-
lar changes can cause tear film instability, leaving the
cornea and conjunctiva more exposed to external agents
[14]. Some studies describe the conjunctival changes
related to the use of topical antiglaucomatous drugs; how-
ever, little is known about the effects of conjunctival
prostaglandin analogues [15]. Most research were
conducted with latanoprost, but there is still insufficient
information on the effects of other newer analogues such
as bimatoprost and travoprost [4,16]. This study aimed
to evaluate the structural and inflammatory changes
induced by fixed combinations of prostaglandin analogues
(latanoprost, travoprost and bimatoprost) and timolol
maleate.Methods
Thirty New Zealand female rabbits, on average 4 months
old and weighing 1.5 kg, were divided into three groups
of ten. For 30 days, the left eye of each animal received
one drop of eye solution with the fixed combination of
timolol 0.5% associated with one of the following prosta-
glandin analogues at 5 pm: group 1 received bimatoprost
0.03%; group 2, travoprost 0.004%; group 3, latanoprost
0.005%. The right eyes served as controls and received
no medication. The assessment was conducted within 30
days, as in previous studies, and observed changes in the
conjunctiva and the use of immunohistochemistry
showed higher accuracy and evaluated data very early.
After 30 days, all rabbits were euthanized, and subse-
quent bilateral enucleation was performed. The eyes
were immediately treated with 10% formaldehyde for
24 h. The superior limbus was marked before processing
because we tried to assess the location of a possible
filtering surgery and to compare similar areas in two
eyes; because there may be a change according to the
location, there should be less depot medications, nasal
and temporal greatest environmental exposure and
keratinization. Next, eyes were sectioned and passed
through pattern processing dehydration with increasing
degrees of alcohol, up to 90% absolute alcohol, andsubsequent clarification with xylene, embedded in paraffin
[17]. Microtome was used for sectioning the paraffin
block stained with hematoxylin-eosin (HE) and periodic
acid-Schiff (PAS) and sustained immunohistochemistry
(IHC) with the following label: anti-actin (ICN
Biochemicals, Irvine, CA, USA; dilution 1:10) blades.
Specimens stained with HE, PAS and anti-actin were
photographed under ×400 magnification and analysed
with the Image-Pro Plus 4.5 software (Media Cybernetics,
Silver Spring, MD, USA). Points of each blade were
chosen, corresponding to a conjunctival flap closest to the
limbus. Each image, including the epithelium and lamina
propria, was virtually barred (150 × 200 mm), and the
three subfields closer to the epithelium were then
evaluated to enable a more specific analysis of the
subepithelial region of the conjunctiva, and not of its lam-
ina propria in each slide.
The following parameters were histomorphometrically
evaluated: number of inflammatory cells (HE), epithelial
thickness (HE) and number of goblet cells (PAS). In
IHC, the following was observed: qualitative assessment
of the degree of fibrosis (fibroblasts marked by actin),
which was classified as minimum [1], mild [2], moderate
[3] and severe [4]. The statistics of numerical variables
was performed with the one-way ANOVA test with a
significance level of 5%, followed by the post-hoc Tukey-
Kramer test. The evaluation of ordinal categorical
variables (degree of fibrosis marker in anti-actin) was
performed using analysis of descriptive statistics and
Fisher's exact test. The experimental procedures were
approved by the Ethics Committee on Animal Use of the
Department of Agrarian Sciences, Federal University of
Parana (CEUA in SCA 038/2008).Results
An increase was observed in the number of conjunctival
inflammatory cells in all groups when compared to the
control eyes. There was no significant difference among
groups of treated eyes (Table 1; Figures 1 and 2).
The conjunctival epithelial thickness is also increased
in all treated eyes. This increase was more intense in the
group treated with latanoprost + timolol (19.44 ± 2.83 to
26.55 ± 4.75; P = 0.0004), followed by the group treated
with travoprost + timolol (18.74 ± 2.08 to 23.88 ± 3.94;
P = 0.0032) and finally that treated with bimatoprost +
timolol (19.56 ± 1.97 to 22.24 ± 3.02; P = 0.0305)
(Graphic 1 in Additional file 1; Figure 2).
The number of goblet cells in treated eyes increased as
compared to control eyes in all groups. There was a no-
ticeable difference in eyes treated with bimatoprost +
timolol (16.11 ± 2.42) and those treated with latanoprost +
timolol (13.18 ± 1.60; P = 0.016) (Figure 3).
Table 1 Results of parameters in groups of fixed combinations: inflammatory cells, epithelial thickness and goblet cells
Parameters Stain Bimatoprost + timolol Travoprost + timolol Latanoprost + timolol
Control Treated P Control Treated P Control Treated P
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Inflammatory cells HE 17.44 5.03 34.4 10.12 0.0003 17.11 3.1 33.33 6.26 0.0001 18.54 3.64 30.72 5.97 0.0001
Epithelial thickness HE 19.56 1.97 22.24 3.02 0.0305 18.75 2.08 23.88 3.94 0.0032 19.44 2.83 26.55 4.75 0.0004
Goblet cells PAS 8.6 1.17 16.11 2.42 0.0001 8 0.71 14.44 1.42 0.0001 7.9 1.37 13.18 1.6 0.0001
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groups) stained with anti-actin demonstrated some de-
gree of fibrosis. In the control eyes, this degree ranged
from minimal to mild. In eyes treated with timolol +
travoprost, a greater degree of fibrosis was observedFigure 1 Photomicrographs of conjunctiva (magnification of ×400) st
inflammatory cells in eyes treated with (B) bimatoprost + timolol, (C) travo
control eye.(median, 3), followed by the bimatoprost + timolol
group (median, 2.5) and then the latanoprost + timolol
group (median, 2). These differences, while displaying a
numerical trend, were not statistically significant
(Graphic 2 in Additional file 1; Figure 4).ained with HE. The photomicrographs show the increase of
prost + timolol and (D) e latanoprost + timolol, compared to (A) the
Figure 2 Photomicrographs of conjunctiva (magnification of ×400) stained with HE. The photomicrographs show the increase in the
epithelial thickness in eyes treated with (B) bimatoprost + timolol, (C) latanoprost + timolol and (D) e travoprost + timolol, compared to (A) the
control eye. The largest thickness was observed in the group treated with latanoprost + timolol.
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Treatment with topical antiglaucoma drugs has been
associated with ocular surface disease, which includes an
increase in the subepithelial collagen deposition, reduc-
tion of the number of goblet cells and increased number
of mast cells, fibroblasts, lymphocytes and macrophages
in the substantia itself. In addition to the effects of
conjunctival changes, a delay in the corneal epithelial re-
generation and tear film instability due to a reduction in
the portion of tear mucus occur. These changes cause
discomfort at instillation of eye drops and become a po-
tential risk of filtering failure in surgical procedures such
as trabeculectomy [11,14,18]. A study by Baudouin et al.
[13] which evaluated the conjunctiva, using biopsy of
patients treated with long-term use of antiglaucoma
drugs, found a high concentration of macrophages,
lymphocytes, mast cells and fibroblasts besides a reduc-
tion in the number of goblet cells.
In this study, an increase in the number of inflamma-
tory cells was noticed in eyes treated with a fixed com-
bination of timolol maleate and prostaglandin analogues.However, there also was an increased number of goblet
cells in all groups (latanoprost + timolol, travoprost +
timolol and bimatoprost + timolol). This increase is
probably associated with the prostaglandin analogues,
and not to timolol, since previous studies have shown
that beta blockers induce a reduction in the number of
goblet cells and tear production [19]. Russ et al. [16] also
observed an increase in the conjunctival goblet cells in
rabbits treated with prostaglandin analogues, which was
not observed in those treated with the timolol.
Another fact to be considered is the result of a study
that showed that goblet cell hyperplasia of the conjunc-
tiva is associated with polluted environments, indicating
that this increase may be an ocular response to external
aggression [20]. The increase in goblet cells caused by
prostaglandin analogues can be associated with a pro-
tective effect of the ocular surface but could also be a re-
flection of the higher capacity for external aggression of
these drugs. Russ et al. [16] observed a less severe in-
flammatory infiltrate in groups treated with prostaglan-
din analogues than in the group treated with timolol.
Figure 3 Photomicrographs of conjunctiva (magnification of ×400) stained with PAS. The photomicrographs show the higher increase in
the number of goblet cells in eyes treated with (B) bimatoprost + timolol and (D) travoprost+timolol and the lower increase in eyes treated with
(C) latanoprost + timolol, compared to (A) the control eye.
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ber of inflammatory cells in all treated eyes, but there
was no difference in the degree of inflammatory reaction
incited by comparing the three combinations. This in-
crease is probably more related to timolol than the pros-
taglandin analogues. Another factor to be considered is
the presence of benzalkonium chloride (BAK) in such
formulations. BAK is the most commonly used preserva-
tive in antiglaucoma drugs [14]. Many studies have
related the effect of cell toxicity and inflammation of the
ocular surface caused by topical ophthalmic therapy with
BAK [21]. Comparisons between use of non-preserved
timolol and timolol preserved with BAK showed a lower
level of toxic effects in the first group and induction of
inflammatory infiltrate in the group treated with the pre-
servative [13]. In vitro studies showed that none of pros-
taglandin analogues appear to induce direct stimulation
of inflammatory pathways involving adhesion moleculesor class II antigens. This pattern of toxicity seems to be
associated with BAK. Latanoprost and travoprost have
been considered as responsible for the protective effects
against BAK toxicity, possibly related to antioxidant
properties [15]. This protective inflammatory effect was
proposed by Guenoun et al. [22], who noted, in vitro,
that prostaglandins tended to be less toxic when
compared to BAK. Cvenkel and Ihan [23] carried out
flow cytometry to determine the levels of HLA-DR
(molecules expressed by macrophages, B lymphocytes
and activated T lymphocytes) in patients' imprint
cytology conjunctival samples without clinical signs of
inflammation, treated with antiglaucomatous drugs
(latanoprost, betaxolol and timolol) containing BAK pre-
servative. It was noticed that all treated eyes, regardless
of the drug applied, showed increased expression of
HLA-DR, which indicates that topical therapy with BAK
induces subclinical inflammation of the conjunctiva.
Figure 4 Photomicrographs of conjunctiva (magnification of ×400) stained with anti-actin. The photomicrographs show the increase in
number of fibroblasts in eyes treated with (B) travoprost + timolol, (C) latanoprost + timolol and (D) bimatoprost + timolol, compared to (A) the
control eye.
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in patients treated for more than 3 years with
antiglaucomatous drugs, isolated or in combination (beta
blockers, miotics and sympathomimetics). These studies
have shown a reduction in the number of goblet cells,
an increased number of macrophages and lymphocytes
in the conjunctival epithelium and increased number of
fibroblasts, macrophages, mast cells and lymphocytes in
the substantia itself, as well as epithelial metaplasia with
alterations in the epithelium structure. The compared
treatments in this study showed that the conjunctiva
was affected in different ways, the main effect occurring
in protocols associated to more than one drug. The
increased epithelial thickness observed is consistent with
results previously reported in literature.
In an experiment conducted in rabbits by Mietz et al.
[18], it was noted that eyes treated with preservedtimolol were stained with anti-actin antibody, an anti-
body directed to the proteins of the cellular cytoskeleton
of fibroblasts. In our study, the subepithelium of the
treated eyes of all groups was stained with the same
antibody. There was no significant difference between
groups, but a numerical trend with a more intense de-
gree of reaction in the group treated with travoprost +
timolol was noticed.
Conclusion
The evaluation of the inflammatory infiltrate in the
treated eyes, in this study, showed no difference in the
number of inflammatory cells, comparing the three fixed
combinations. The fixed combination travoprost + timo-
lol showed a higher degree of fibrosis. The fixed combin-
ation of bimatoprost + timolol led to a greater increase
in the number of goblet cells.
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Additional file 1: Graphic 1. shows the epithelial thickness of rabbit
conjunctiva (HE), comparing control to treated eyes in the three groups:
bimatoprost + timolol (G1), travoprost + timolol (G2) and latanoprost +
timolol (G3). Observe the increase in epithelial thickness in all treated
eyes, comparing to their respective controls, especially in latanoprost +
timolol. Histological evaluation performed with HE.Graphic 2. shows the
degree of conjunctival fibrosis of rabbit comparing the controls with the
treated eyes in the three groups: bimatoprost + timolol (G1), travoprost +
timolol (G2) and latanoprost + timolol (G3). A higher degree of fibrosis
was observed in eyes treated with travoprost + timolol.
Immunohistochemical evaluation performed with anti-actin.
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